Globus Medical, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the fiscal quarter ended September 30, 2026.

Key Highlights

  • Total assets: $5,528,193 thousand as of September 30, 2026, up from $5,302,761 thousand at December 31, 2025, according to the filing.
  • Cash and cash equivalents: $441,272 thousand at September 30, 2026, compared with $526,156 thousand at December 31, 2025.
  • Retained earnings: $1,525,490 thousand at September 30, 2026, up from $1,387,957 thousand at December 31, 2025.
  • Inventories: $824,144 thousand at September 30, 2026, compared with $759,277 thousand at December 31, 2025.
  • Shares outstanding: 110,041,596 Class A shares and 22,430,097 Class B shares as of November 2, 2026, the filing stated.
  • Total equity: $4,796,250 thousand at September 30, 2026, versus $4,573,250 thousand at December 31, 2025.

Globus Medical Balance Sheet Position at September 30, 2026

Globus Medical, Inc. (NYSE:GMED), headquartered in Audubon, Pennsylvania, reported total assets of $5,528,193 thousand at September 30, 2026, according to the unaudited condensed consolidated balance sheets included in the filing. This compares with total assets of $5,302,761 thousand at December 31, 2025. Total liabilities stood at $731,943 thousand, leaving total equity of $4,796,250 thousand at the end of the quarter.

The filing disclosed that cash and cash equivalents declined to $441,272 thousand from $526,156 thousand at December 31, 2025, while long-term marketable securities increased significantly, from $71,819 thousand to $353,738 thousand over the same period. Inventories rose to $824,144 thousand from $759,277 thousand. Goodwill was reported at $1,453,561 thousand, up from $1,435,033 thousand at year-end 2025, and intangible assets, net, were $667,468 thousand, down from $745,064 thousand.

On the equity side, the filing noted that Class A common stock shares issued and outstanding decreased to 110,235,170 at September 30, 2026, from 112,625,126 at December 31, 2025, while Class B shares remained unchanged at 22,430,097. Additional paid-in capital was reported at $3,259,292 thousand and retained earnings at $1,525,490 thousand. The company disclosed it is a large accelerated filer and is not a shell company. The filing noted forward-looking statements are subject to risks and uncertainties described in the company's cautionary language and in its Annual Report on Form 10-K for the year ended December 31, 2025.

What Was Disclosed

Globus Medical filed its unaudited Form 10-Q for the quarter ended September 30, 2026, disclosing balance sheet data showing growth in total assets and equity relative to December 31, 2025, alongside changes in cash, marketable securities, inventories, and share counts.